60 DEGREES PHARMACEUTICALS, INC. — All Filings
195 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
3
4
424B4
424B5
8-A12B
8-A12B/A
8-K
CERT
CORRESP
D
DEF 14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-Q
PRE 14A
S-1
S-1/A
S-3
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | CURRENT REPORT | 0001213900-26-032352 | Mar 20, 2026 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-26-027763 | Mar 13, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-26-027756 | Mar 13, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-26-027008 | Mar 12, 2026 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-26-026237 | Mar 11, 2026 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-26-022325 | Mar 2, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-26-015239 | Feb 12, 2026 | Feb 11, 2026 |
| 8-K | CURRENT REPORT | 0001213900-26-007330 | Jan 23, 2026 | Jan 20, 2026 |
| 8-K | CURRENT REPORT | 0001213900-26-006179 | Jan 21, 2026 | Jan 14, 2026 |
| 8-K | CURRENT REPORT | 0001213900-26-002359 | Jan 8, 2026 | — |
| 4 | — | 0001213900-25-122379 | Dec 16, 2025 | Dec 15, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001213900-25-120948 | Dec 12, 2025 | Dec 10, 2025 |
| SCHEDULE 13G/A | — | 0001493152-25-022267 | Nov 13, 2025 | — |
| 10-Q | 10-Q | 0001554855-25-002032 | Nov 13, 2025 | Sep 30, 2025 |
| SCHEDULE 13G/A | — | 0001213900-25-107730 | Nov 7, 2025 | — |
| SCHEDULE 13G/A | — | 0001649553-25-000204 | Nov 7, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-098131 | Oct 10, 2025 | Oct 8, 2025 |
| 4 | — | 0001213900-25-087681 | Sep 15, 2025 | Sep 12, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-085853 | Sep 9, 2025 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-085050 | Sep 5, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-085040 | Sep 5, 2025 | Sep 3, 2025 |
| DEFR14A | DEFINITIVE PROXY STATEMENT | 0001213900-25-082789 | Sep 2, 2025 | — |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-25-080878 | Aug 27, 2025 | Oct 8, 2025 |
| PRE 14A | PRELIMINARY PROXY STATEMENT | 0001213900-25-077435 | Aug 15, 2025 | — |
| 4 | — | 0001213900-25-076984 | Aug 14, 2025 | Sep 26, 2024 |
| 4 | — | 0001213900-25-076983 | Aug 14, 2025 | Jan 17, 2025 |
| 3 | — | 0001213900-25-076982 | Aug 14, 2025 | Feb 12, 2024 |
| 10-Q | 10-Q | 0001554855-25-001009 | Aug 13, 2025 | Jun 30, 2025 |
| SCHEDULE 13G | — | 0001649553-25-000133 | Jul 22, 2025 | — |
| SCHEDULE 13G | — | 0001213900-25-065799 | Jul 18, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-065718 | Jul 18, 2025 | Jul 15, 2025 |
| SCHEDULE 13G/A | — | 0001641172-25-020075 | Jul 17, 2025 | — |
| SCHEDULE 13G | — | 0001641172-25-020072 | Jul 17, 2025 | — |
| 424B4 | PROSPECTUS | 0001213900-25-064472 | Jul 16, 2025 | — |
| EFFECT | — | 9999999995-25-002259 | Jul 15, 2025 | — |
| CORRESP | — | 0001213900-25-062836 | Jul 10, 2025 | — |
| CORRESP | — | 0001213900-25-062810 | Jul 10, 2025 | — |
| S-1 | REGISTRATION STATEMENT | 0001213900-25-061842 | Jul 7, 2025 | — |
| UPLOAD | — | 0000000000-25-006259 | Jun 13, 2025 | — |
| 4 | — | 0001213900-25-052709 | Jun 9, 2025 | — |
| DRS | — | 0001213900-25-052232 | Jun 6, 2025 | — |
| 4 | — | 0001213900-25-051700 | Jun 5, 2025 | Jun 3, 2025 |
| SCHEDULE 13G/A | — | 0001172661-25-002208 | May 15, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-043779 | May 15, 2025 | Mar 31, 2025 |
| SCHEDULE 13G | — | 0001641172-25-010196 | May 14, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-030102 | Apr 9, 2025 | Apr 4, 2025 |
| EFFECT | — | 9999999995-25-000945 | Apr 2, 2025 | — |
| CORRESP | — | 0001213900-25-026133 | Mar 31, 2025 | — |
| S-1/A | AMENDMENT NO. 1 TO FORM S-1 | 0001013762-25-003353 | Mar 27, 2025 | — |
| 10-K | ANNUAL REPORT | 0001013762-25-003343 | Mar 27, 2025 | Dec 31, 2024 |